The discussion paper on compulsory licensing of patents will have achieved its purpose if it can lead to a proactive policy in the area of drugs and health. IN a proactive move to ensure a fair balance between protection of Intellectual Property rights and protection of the public interest, the Department of Industrial Policy and Promotion (DIPP) of the Ministry of Commerce and Industry has chosen to put out a discussion...

What happens in open standards? All technology/software used for e-governance becomes inter-operable. In other words, any technology platform or software should be able to read government documents, maps, images and datasheets. Who gains? Government: Will not have to spend crores on a proprietary standard. Various offices would be able to access data without having same technology/software. Consumers: Will not have to buy proprietary software to access government documents Who loses? Big proprietary software companies and licensed...

After successfully contesting a patent dispute with China earlier this year — regarding formulations based on “pudina” (mint) and “kalamegha” (Andrographis) — India last week won another legal battle in Malaysia against the use of “ponni” rice as trademark. Like basmati, ponni is also a speciality rice grown exclusively in southern states and has a niche market abroad. These and other victories concerning patenting of products like neem (Azadirachta indica)...

The 2010 Seeds Bill that has been introduced in Parliament does address some of the major concerns in the aborted 2004 version, but strangely a number of important correctives – on regulation, consistency and punishment – that had been incorporated in the 2008 version (which lapsed in 2009) have now been modified or dropped altogether. What forces are pushing the government to act against the interests of India’s farmers? The third...

Their ongoing negotiations remain shrouded in secrecy, but there are already reports that India and the European Union (EU) will have a free-trade agreement ready by the end of August, and that they will be putting signatures to it before the end of 2010. Yet it is a potential development that is causing more nervous chatter than joyous jitters here in India, where drug manufacturers in particular have raised concerns over...